Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot International flag

This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions

Example Group: Remdesivir_IV_200_mg_once_then_100_mg_once_daily_for_9_days

Generated Narrative: Group

Resource Group "179783" Version "3" Updated "2023-12-04 20:29:22+0000"

Profile: ExposureDefinition

Artifact related artifact:

Artifact Title: Remdesivir IV 200 mg once then 100 mg once daily for 9 days

Artifact URL: https://fevir.net/resources/Group/179783

Artifact Publisher: Computable Publishing LLC

Artifact Copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/

Artifact Contact: support@computablepublishing.com

Artifact Author: Brian S. Alper:

modifierExtension[http://hl7.org/fhir/StructureDefinition/artifact-status]

identifier: FEvIR Object Identifier: 179783

type: animal

membership: definitional

name: Remdesivir_IV_200_mg_once_then_100_mg_once_daily_for_9_days

description: Remdesivir IV 200 mg once then 100 mg once daily for 9 days

Characteristics

-ExtensionCodeValue[x]Exclude
*Defined by Reference ()ActivityDefinition/213: IV remdesivir 200 mg then 100 mg/day for 9 days "IV_remdesivir_200_mg_then_100_mg_day_for_9_days"false